# A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

> **NCT05820672** · — · RECRUITING · sponsor: **Ascendis Pharma Endocrinology Division A/S** · enrollment: 900 (estimated)

## Conditions studied

- Growth Hormone Deficiency

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05820672
- **Lead sponsor:** Ascendis Pharma Endocrinology Division A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-20
- **Primary completion:** 2033-03
- **Final completion:** 2033-03
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05820672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05820672, "A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05820672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*